Abstract
Oropouche virus (OROV) is an arbovirus endemic to the Amazon region since the 1950s that re-emerged in late 2023, causing a major epidemic across Central and South America. Here we investigated the transmission dynamics of the 2023–2024 epidemic in Manaus City (Amazonas state, Brazil), a major metropolitan hub in the Amazon, and estimated OROV infections across Latin America and the Caribbean. OROV re-emergence in Manaus resulted in an increase of IgG seroprevalence from 11.4% in November 2023 to 25.7% in November 2024. The neutralizing capacity of OROV-specific IgG antibodies from individuals collected before and after the re-emergence demonstrated a median plaque reduction neutralization test 50% titer of 640 against both the historical and contemporary OROV isolates. A historical reconstruction of OROV circulation in Manaus indicated a continuous low-level transmission with two major outbreaks of comparable seasonality and magnitude in 1980–1981 and 2023–2024. We estimate approximately 336,000 OROV infections in the Amazon region under a scenario of continuous endemic transmission without major outbreaks and over 9.4 million OROV infections during major outbreaks from 1960 to 2025. Collectively, our findings provide a comprehensive assessment of OROV transmission in Manaus and contribute to a better understanding of the OROV burden.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
All codes and data used to generate the figures in this article are publicly available via GitHub at https://github.com/wmarciel/Oropouche-LAC. We obtained shapefiles from the Brazilian Institute of Geography and Statistics and the Centers for Disease Control and Prevention, respectively. De-identified individual-level data from the Brazilian Ministry of Health can be provided for research purposes after approval by a committee on human experimentation (if applicable). These data can be obtained upon request to the corresponding authors. The estimated response time from the corresponding authors may be up to 3 weeks.
References
Travassos da Rosa, J. F. et al. Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected orthobunyavirus. Am. J. Trop. Med. Hyg. 96, 1019–1030 (2017).
de Souza, W. M. et al. ICTV virus taxonomy profile: Peribunyaviridae 2024. J. Gen. Virol. https://doi.org/10.1099/jgv.0.002034 (2024).
de Lima, S. T. S. et al. Molecular epidemiology of Oropouche virus, Ceará State, Brazil, 2024. Emerg. Infect. Dis. 31, 838–842 (2025).
das Neves Martins, F. E. et al. Newborns with microcephaly in Brazil and potential vertical transmission of Oropouche virus: a case series. Lancet Infect. Dis. 25, 155–165 (2025).
Bandeira, A. C. et al. Fatal Oropouche virus infections in nonendemic region, Brazil, 2024. Emerg. Infect. Dis. 30, 2370–2374 (2024).
Hughes, H. R. et al. ICTV virus taxonomy profile: Peribunyaviridae. J. Gen. Virol. 101, 1–2 (2020).
Tilston-Lunel, N. L. Oropouche virus: an emerging orthobunyavirus. J. Gen. Virol. 105, 002027 (2024).
Aguilar, P. V. et al. Iquitos virus: a novel reassortant Orthobunyavirus associated with human illness in Peru. PLoS Negl. Trop. Dis. 5, e1315 (2011).
Ladner, J. T. et al. Genomic and phylogenetic characterization of viruses included in the Manzanilla and Oropouche species complexes of the genus Orthobunyavirus, family Bunyaviridae. J. Gen. Virol. 95, 1055–1066 (2014).
Tilston-Lunel, N. L. et al. Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence. J. Gen. Virol. 96, 1636–1650 (2015).
Briese, T., Bird, B., Kapoor, V., Nichol, S. T. & Lipkin, W. I. Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. J. Virol. 80, 5627–5630 (2006).
Scachetti, G. C. et al. Re-emergence of Oropouche virus between 2023 and 2024 in Brazil: an observational epidemiological study. Lancet Infect. Dis. 25, 166–175 (2025).
Naveca, F. G. et al. Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region. Nat. Med. 30, 3509–3521 (2024).
Srivastava, S. et al. The emergence of oropouche fever: a potential new threat? New Microbes New Infect. 65, 101596 (2025).
McDonald, E. et al. Surveillance for West Nile virus disease—United States, 2009–2018. Am. J. Transplant. 21, 1959–1974 (2021).
Rodriguez-Morales, A. J. et al. Reemergence of Oropouche virus infection in Ecuador, 2024: vectors and cases. J. Infect. 91, 106544 (2025).
Bello-Rodríguez, B. M., Vega-Jiménez, J., Cañete, R. & Rodriguez-Morales, A. J. Emergence of Oropouche virus infection in Matanzas, Cuba, 2024. J. Infect. 90, 106470 (2025).
Cruz, C. D. et al. Co-circulation of 2 Oropouche virus lineages during outbreak, Amazon region of Peru, 2023–2024. Emerg. Infect. Dis. 31, 879–881 (2025).
Usuga, J. et al. Co-circulation of 2 Oropouche virus lineages, Amazon Basin, Colombia, 2024. Emerg. Infect. Dis. 30, 2375–2380 (2024).
Capobianchi, M. R., Castilletti, C. & Gobbi, F. G. Potential risks of Oropouche virus importation into Europe. J. Travel Med. 31, taae109 (2024).
Morrison, A. et al. Oropouche virus disease among US travelers—United States, 2024. MMWR Morb. Mortal. Wkly Rep. 73, 769–773 (2024).
Scroggs, S. L. P. et al. Enhanced infection and transmission of the 2022–2024 Oropouche virus strain in the North American biting midge Culicoides sonorensis. Sci. Rep. 15, 27368 (2025).
Gräf, T. et al. Expansion of Oropouche virus in non-endemic Brazilian regions: analysis of genomic characterisation and ecological drivers. Lancet Infect. Dis. 25, 379–389 (2025).
Lapola, D. M. et al. The drivers and impacts of Amazon forest degradation. Science 379, eabp8622 (2023).
Borborema, C. A. et al. [1st occurrence of outbreaks caused by Oropouche virus in the State of Amazonas]. Rev. Inst. Med. Trop. Sao Paulo 24, 132–139 (1982).
Fischer, C. et al. The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling study. Lancet Infect. Dis. 25, 1020–1032 (2025).
de Melo Iani, F. C. et al. Travel-associated international spread of Oropouche virus beyond the Amazon. J. Travel Med. 32, taaf018 (2025).
Tian, H. et al. Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia. PLoS Negl. Trop. Dis. 11, e0005694 (2017).
Nunes, M. R. et al. Air travel is associated with intracontinental spread of dengue virus serotypes 1–3 in Brazil. PLoS Negl. Trop. Dis. 8, e2769 (2014).
Nunes, M. R. et al. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med. 13, 102 (2015).
Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345–349 (2016).
de Souza, W. M. & Weaver, S. C. Effects of climate change and human activities on vector-borne diseases. Nat. Rev. Microbiol. 22, 476–491 (2024).
Toledo-Teixeira, D. A. et al. MyD88 signalling in B cells and antibody responses during Oropouche virus-induced neurological disease in mice. eBioMedicine 117, 105815 (2025).
Ribeiro Dos Santos, G. et al. Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns. Nat. Med. 31, 2342–2349 (2025).
Mellor, P. S., Boorman, J. & Baylis, M. Culicoides biting midges: their role as arbovirus vectors. Annu. Rev. Entomol. 45, 307–340 (2000).
Feitoza, L. H. M. et al. Influence of meteorological and seasonal parameters on the activity of Culicoides paraensis (Diptera: Ceratopogonidae), an annoying anthropophilic biting midge and putative vector of Oropouche Virus in Rondônia, Brazilian Amazon. Acta Trop. 243, 106928 (2023).
de Souza, W. M., Lecuit, M. & Weaver, S. C. Chikungunya virus and other emerging arthritogenic alphaviruses. Nat. Rev. Microbiol. 23, 585–601 (2025).
de Souza, W. M. et al. Chikungunya: a decade of burden in the Americas. Lancet Reg. Health Am. 30, 100673 (2024).
Bustos Carrillo, F. et al. Epidemiological evidence for lineage-specific differences in the risk of inapparent Chikungunya virus infection. J. Virol. https://doi.org/10.1128/JVI.01622-18 (2019).
Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536–2543 (2009).
Lim, A. et al. The overlapping global distribution of dengue, Chikungunya, Zika and yellow fever. Nat. Commun. 16, 3418 (2025).
Weiss, D. J. et al. Global maps of travel time to healthcare facilities. Nat. Med. 26, 1835–1838 (2020).
Population Census 2022. Instituto Brasileiro de Geografia e Estatística https://www.ibge.gov.br/en/statistics/social/labor/22836-2022-census-3.html (2022).
Population Census 2010. Instituto Brasileiro de Geografia e Estatística https://www.ibge.gov.br/en/statistics/social/labor/18391-2010-population-census.html?edicao=19720 (2010).
Obolski, U. et al. MVSE: an R-package that estimates a climate-driven mosquito-borne viral suitability index. Methods Ecol. Evol. 10, 1357–1370 (2019).
ERA5 hourly data on single levels from 1940 to present. Climate Data Store https://cds.climate.copernicus.eu/datasets/reanalysis-era5-single-levels?tab=overview (2025).
Pinheiro, F. P., Hoch, A. L., Gomes, M. L. & Roberts, D. R. Oropouche virus. IV. Laboratory transmission by Culicoides paraensis. Am. J. Trop. Med. Hyg. 30, 172–176 (1981).
Mercer, D. R., Spinelli, G. R., Watts, D. M. & Tesh, R. B. Biting rates and developmental substrates for biting midges (Diptera: Ceratopogonidae) in Iquitos, Peru. J. Med. Entomol. 40, 807–812 (2003).
In 2023, life expectancy reaches 76.4 years; surpasses pre-pandemic level. Instituto Brasileiro de Geografia e Estatística https://agenciadenoticias.ibge.gov.br/en/agencia-news/2184-news-agency/news/42021-in-2023-life-expectancy-reaches-76-4-years-surpasses-pre-pandemic-level (2024).
Guagliardo, S. A. J. et al. Estimation of incubation period for Oropouche virus disease among travel-associated cases, 2024–2025. Emerg. Infect. Dis. 31, 1337–1343 (2025).
Pinheiro, F. P., Travassos da Rosa, A. P., Gomes, M. L., LeDuc, J. W. & Hoch, A. L. Transmission of Oropouche virus from man to hamster by the midge Culicoides paraensis. Science 215, 1251–1253 (1982).
Proenca-Modena, J. L. et al. Interferon-regulatory factor 5-dependent signaling restricts Orthobunyavirus dissemination to the central nervous system. J. Virol. 90, 189–205 (2016).
Hoze, N. et al. RSero: a user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies. PLoS Comput. Biol. 21, e1012777 (2025).
Pinheiro, F. P. et al. Oropouche virus. I. A review of clinical, epidemiological, and ecological findings. Am. J. Trop. Med. Hyg. 30, 149–160 (1981).
Pinheiro, F. F., Pinheiro, M., Bensabath, G., Caucsey, O. R. & Shope, R. Epidemia de vírus Oropouche em Belém. Mem. Inst. Evandro Chagas 12, 15–23 (1962).
Pinheiro, F. P., Travassos da Rosa, A. P. A. & Vasconcelos, P. F. C. in An Overview of Arbovirology in Brazil and Neighbouring Countries (eds Travassos da Rosa, A. P. A. et al.) 186–192 (Instituto Evandro Chagas, 1998).
Pinheiro, F. P., Travassos da Rosa, A. P., Travassos da Rosa, J. F. & Bensabath, G. An outbreak of Oropouche virus diease in the vicinity of Santarem, Para, Brazil. Tropenmed. Parasitol. 27, 213–223 (1976).
LeDuc, J. W., Hoch, A. L., Pinheiro, F. P. & da Rosa, A. P. Epidemic Oropouche virus disease in northern Brazil. Bull. Pan Am. Health Organ. 15, 97–103 (1981).
Tesh, R. B. The emerging epidemiology of Venezuelan hemorrhagic fever and Oropouche fever in tropical South America. Ann. N. Y. Acad. Sci. 740, 129–137 (1994).
Freitas, R. B. et al. in Internacional Simposium on Tropical Arboviruses and Haemorrhagic Fevers Vol. 25, 59–72 (Fundação Serviços de Saúde Pública, 1980).
Vasconcelos, P. F. et al. [1st register of an epidemic caused by Oropouche virus in the states of Maranhao and Goias, Brazil]. Rev. Inst. Med. Trop. Sao Paulo 31, 271–278 (1989).
Vasconcelos, P. F. et al. Inadequate management of natural ecosystem in the Brazilian Amazon region results in the emergence and reemergence of arboviruses. Cad. Saude Publica 17, 155–164 (2001).
Rosa, A. P. et al. [Outbreak of oropouche virus fever in Serra Pelada, municipality of Curionopolis, Para, 1994]. Rev. Soc. Bras. Med. Trop. 29, 537–541 (1996).
Chavez, R., Colan, E. & Phillips, I. Fiebre de Oropouche en Iquitos: reporte preliminar de 5 casos. Rev. Farmacol. Terap. 2, 12–14 (1992).
Forshey, B. M. et al. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl. Trop. Dis. 4, e787 (2010).
Azevedo, R. S. et al. Reemergence of Oropouche fever, northern Brazil. Emerg. Infect. Dis. 13, 912–915 (2007).
Vasconcelos, H. B. et al. Oropouche fever epidemic in Northern Brazil: epidemiology and molecular characterization of isolates. J. Clin. Virol. 44, 129–133 (2009).
Vasconcelos, H. B. et al. Molecular epidemiology of Oropouche virus, Brazil. Emerg. Infect. Dis. 17, 800–806 (2011).
Alert ID: 449016 PRO/EDR Oropouche—Peru (02): (SM). ProMED International Society for Infectious Diseases www.promedmail.org (2010).
Alvarez-Falconi, P. P. & Rios Ruiz, B. A. Brote de fiebre de Oropuche en Bagazán, San Martín - Perú: evaluación epidemiológica, manifestaciones gastrointestinales y hemorrágicas. Rev. Gastroenterol. Peru 30, 334–340 (2010).
Castro, S. et al. Brote de fiebre de Oropuche en dos localidades de la región Cajamarca, Perú, 2011. Rev. Peru Epidemiol. 17, 1–6 (2013).
Romero-Alvarez, D. & Escobar, L. E. Vegetation loss and the 2016 Oropouche fever outbreak in Peru. Mem. Inst. Oswaldo Cruz 112, 292–298 (2017).
Silva-Caso, W. et al. First outbreak of Oropouche Fever reported in a non-endemic western region of the Peruvian Amazon: molecular diagnosis and clinical characteristics. Int. J. Infect. Dis. 83, 139–144 (2019).
Garcia, M. P. et al. [Detection of Oropouche viral circulation in Madre de Dios region, Peru (December 2015 to january 2016)]. Rev. Peru. Med. Exp. Salud Publica 33, 380–381 (2016).
Martins-Luna, J. et al. Oropouche infection a neglected arbovirus in patients with acute febrile illness from the Peruvian coast. BMC Res. Notes 13, 67 (2020).
Carvalho, V. L. et al. Arbovirus outbreak in a rural region of the Brazilian Amazon. J. Clin. Virol. 150-151, 105155 (2022).
Gaillet, M. et al. Outbreak of Oropouche virus in French Guiana. Emerg. Infect. Dis. 27, 2711–2714 (2021).
Dixon, K. E., Travassos da Rosa, A. P., Travassos da Rosa, J. F. & Llewellyn, C. H. Oropouche virus. II. Epidemiological observations during an epidemic in Santarem, Para, Brazil in 1975. Am. J. Trop. Med. Hyg. 30, 161–164 (1981).
Watts, D. M. et al. Oropouche virus transmission in the Amazon River basin of Peru. Am. J. Trop. Med. Hyg. 56, 148–152 (1997).
Watts, D. M. et al. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am. J. Trop. Med. Hyg. 56, 661–667 (1997).
Baisley, K. J., Watts, D. M., Munstermann, L. E. & Wilson, M. L. Epidemiology of endemic Oropouche virus transmission in upper Amazonian Peru. Am. J. Trop. Med. Hyg. 59, 710–716 (1998).
Tavares-Neto, J. et al. [Serologic survey for yellow fever and other arboviruses among inhabitants of Rio Branco, Brazil, before and three months after receiving the yellow fever 17D vaccine]. Rev. Soc. Bras. Med. Trop. 37, 1–6 (2004).
Watts, D. M. et al. Etiologies of acute undifferentiated febrile illnesses in and near Iquitos from 1993 to 1999 in the Amazon River basin of Peru. Am. J. Trop. Med. Hyg. 107, 1114–1128 (2022).
De Figueiredo, R. M. et al. [Exanthematous diseases and the first epidemic of dengue to occur in Manaus, Amazonas State, Brazil, during 1998–1999]. Rev. Soc. Bras. Med. Trop. 37, 476–479 (2004).
Nunes, M. R. et al. Arbovirus eco-epidemiology in the area affected by the Cuiabá–Santarém Highway (BR-163), Pará State, Brazil]. Cad. Saude Publica 25, 2583–2602 (2009).
Cruz, A. C. et al. [Serological survey for arboviruses in Juruti, Pará State, Brazil]. Cad. Saude Publica 25, 2517–2523 (2009).
da Costa, V. G., de Rezende Feres, V. C., Saivish, M. V., de Lima Gimaque, J. B. & Moreli, M. L. Silent emergence of Mayaro and Oropouche viruses in humans in Central Brazil. Int. J. Infect. Dis. 62, 84–85 (2017).
de Lima, R. C. et al. Oropouche virus exposure in febrile patients during Chikungunya virus introduction in the state of Amapá, Amazon Region, Brazil. Pathogens 13, 469 (2024).
Gil-Mora, J. et al. Arbovirus antibody seroprevalence in the human population from Cauca, Colombia. Am. J. Trop. Med. Hyg. 107, 1218–1225 (2022).
Ciuoderis, K. A. et al. Oropouche virus as an emerging cause of acute febrile illness in Colombia. Emerg. Microbes Infect. 11, 2645–2657 (2022).
Bernardes-Terzian, A. C. et al. Sporadic oropouche virus infection, Acre, Brazil. Emerg. Infect. Dis. 15, 348–350 (2009).
Download GADM data (version 4.1). Global Administrative Areas Database https://gadm.org/download_country.html (2022).
Massicotte, P., South, A. & Hufkens, K. rnaturalearth: world map data from Natural Earth. Version 1.2.0 https://cran.r-project.org/web/packages/rnaturalearth/index.html (2025).
Acknowledgements
W.M.d.S. and N.R.F. were supported by Wellcome Trust Digital Technology Development Award in Climate Sensitive Infectious Disease Modelling (no. 226075/Z/22/Z) and the Wellcome Trust Dengue and Zika Immunology and Genomics Multi-Country Network (DeZi Network; no. 316633/Z/24/Z). J.L.P.-M. is supported by São Paulo Research Foundation (no. 2022/10442-0), National Council for Scientific and Technological Development (CNPq, no. 309971/2023-3). E.R.M. is affiliated with the Wellcome Trust-funded Centres for Antimicrobial Optimization Network (no. 226693/Z/22/Z). V.S.S. was supported by a CNPq fellowship. We acknowledge funding from the MRC Centre for Global Infectious Disease Analysis (no. MR/R015600/1), jointly funded by the UK Medical Research Council and the UK Foreign, Commonwealth and Development Office, under the MRC/FCDO Concordat agreement, and also part of the EDCTP2 program supported by the European Union. A.I.B. was supported by Cornell Atkinson Center seed funding. We thank J. A. Tida (www.plotmyscience.com) for figure editing.
Author information
Authors and Affiliations
Contributions
W.M.d.S., J.L.P.-M. and E.C.S. conceptualized the study. E.R.M., X.H., G.C.S., J.F., I.M.C., G.M.P., L.S., A.C.B., C.F.R., N.B.S.B., S.T.S.d.L., R.d.J., R.B.K., B.B.S., C.M.L.S., N.C.P., V.S.S., R.S.R., P.J.L., A.G.C., J.L.P.-M., E.C.S. and W.M.d.S. contributed to the acquisition of data. X.H., G.C.S., O.C.-A., O.R. and W.M.d.S. contributed to the data analysis. X.H., G.C.S., N.R.F., S.C.W., H.S., J.L.P.-M., E.C.S. and W.M.d.S. contributed to data interpretation. W.M.d.S. and X.H. drafted the paper. X.H., G.C.S., L.S., M.P.C., R.S., O.R., A.I.B., N.R.F., S.C.W., H.S., A.G.C., J.L.P.-M., E.C.S. and W.M.d.S. revised the paper. A.G.C., J.L.P.-M., E.C.S. and W.M.d.S. acquired funding for the study. All authors read and approved the final version of the paper and the submission. X.H. and W.M.d.S. accessed and verified all the data reported in the study.
Corresponding authors
Ethics declarations
Competing interests
A.C.B., C.F.R. and N.B.S.B. are employees of EUROIMMUN Brasil. The other authors declare no competing interests.
Peer review
Peer review information
Nature Medicine thanks Jonas Schmidt-Chanasit, Joseph Wu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: Lia Parkin, in collaboration with the Nature Medicine team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Testing positivity rates and healthcare access in Manaus, Amazonas, and Brazil.
A) Testing positivity rates of Oropouche virus (OROV) for collected samples in 2023 and 2024. Observed rates are shown as dots, and 95% confidence intervals are shown as bars. Data are presented for Manaus (n = 9,345), Amazonas (n = 24,614), and Brazil (n = 187,320). B) Model-predicted relative surveillance capacity index for emerging acute viral infectious diseases. The index ranges from 0 (lowest) to 1 (highest). Data are represented as medians (dots) with interquartile ranges (bars). C) Optimal travel time to healthcare facilities in hours via motorized transport. Data are represented as medians (dots) with interquartile ranges (bars).
Extended Data Fig. 2 Spatiotemporal variation in OROV transmission suitability in Amazonas state, Brazil.
Mean monthly OROV transmission suitability (Index P) for Culicoides paraensis from 2014 to 2024 at the municipality level in Amazonas state. Index P values of ≥1 indicate suitable climate conditions for transmission, and values of <1 indicate unsuitable conditions.
Extended Data Fig. 3 OROV transmission suitability in Manaus City, Brazil.
A) Time series of average weekly index P from 2014 to 2025 in Manaus city, Brazil. The dashed line shows that Index P ≥ 1, which indicates a suitable climate for OROV transmission by C. paraensis. B) The number of days suitable for OROV transmission by C. paraensis per year from 2014 to 2024. The dashed line indicates 6 months of suitable climate for OROV transmission by C. paraensis for the year.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Manuli, E.R., Hua, X., Scachetti, G.C. et al. Transmission dynamics of Oropouche virus in Latin America and the Caribbean. Nat Med (2026). https://doi.org/10.1038/s41591-026-04221-z
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41591-026-04221-z


